<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26966749</identifier>
<setSpec>0327-6139</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Tajima-Pozo, Kazuhiro</dc:author>
<dc:author>Montañés-Rada, Francisco</dc:author>
<dc:author>Rosón-González, Mirian</dc:author>
<dc:description xml:lang="en">A large number of scientific papers have reported the relationship between the development of hyperprolactinemia and the use of psychotropic drugs, especially the role of antipsychotics which are antidopaminergic drugs. However, less information is known about the role of antidepressants in the development of hyperprolactinemia, specially the selective reuptake inhibitors (SSRIs). The prevalence of hyperprolactinemia as a pharmacological side effect of SSRIs is still unknown, despite the widespread use over the last decade. The aim of this review is to explore the relationship between hyperprolactinemia and SSRIs.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2015 Sep-Oct </dc:date>
<dc:title xml:lang="es">Hiperprolactinemia asociada al uso de antidepresivos inhibidores de la recaptación de serotonina. Una revisión narrativa de la literature.</dc:title>
<dc:title xml:lang="en">[HYPERPROLACTINEMIA AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS. A NARRATIVE REVIEW OF THE LITERATURE].</dc:title>
<dc:publisher>Vertex (Buenos Aires, Argentina)</dc:publisher>
</metadata>
</record>
</pubmed-document>
